Premium
Advances in Diabetes Therapy in the Elderly
Author(s) -
Lee Fiona TH
Publication year - 2009
Publication title -
journal of pharmacy practice and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.222
H-Index - 22
eISSN - 2055-2335
pISSN - 1445-937X
DOI - 10.1002/j.2055-2335.2009.tb00707.x
Subject(s) - medicine , diabetes mellitus , insulin , intensive care medicine , dosing , adverse effect , type 2 diabetes , endocrinology
Diabetes is increasing in prevalence and the choice of medication is expanding with the recent introduction of a new class of oral hypoglycaemics. Emerging data on the older oral hypoglycaemics is adding to the complexity of diabetes management, particularly in the elderly for whom special consideration of adverse effects and dosing are required. As diabetes progresses the inevitable decline in pancreatic β‐cell function diminishes the efficacy of the oral hypoglycaemics and insulin is required. The new synthetic long‐acting insulin analogues are useful in the elderly both for ease of administration and to minimise hypoglycaemia. Exogenous insulin often does not provide optimal control of diabetes and it is envisioned that in the future, therapy may target preservation of pancreatic β‐cell function to produce long‐term glycaemic control with endogenous insulin.